A Critical Review of CAR-T Therapies for Glioblastoma: What's Wrong with the Current Attempts?
{{output}}
Today, CAR-T therapy has been widely acknowledged as a "gold standard" treatment for certain hematologic diseases. There is a relatively small but enhancing body of clinical trials studying the effectiveness of CAR-T in treating glioblastoma, known as the mo... ...
